( CPE ) September 21, 2017 Maryam Khan Peel Public Health - - PDF document

2017-09-28 1

PublicHealthOntario.ca

Carbapenemase-Producing Enterobacteriaceae (CPE)

September 21, 2017

Maryam Khan – Peel Public Health Madeleine Ashcroft – Public Health Ontario

PublicHealthOntario.ca

Objectives

Differentiate the acronyms related to CPE (CPE,CPO,CRE,CRO) Discuss the incidence and prevalence of CPE in Peel and Ontario Identify risk factors for acquiring CPE Describe prevention strategies to combat CPE transmission

2017-09-28 2

PublicHealthOntario.ca

Definitions

Multi-Drug Resistant Organism (MDRO) or Antibiotic-Resistant Organism (ARO): Bacteria that have become resistant to certain antibiotics so these antibiotics can no longer be used to control or kill the bacteria for example, MRSA, VRE,CPE, etc. Carbapenems: A class of broad spectrum antibiotics that are used for treating infection caused by resistant bacteria (e.g. ertapenem, meropenem, imipenem, doripenem)

PublicHealthOntario.ca

Definitions

Carbapenemase Genes: Genes, made up of DNA, that instruct the bacteria to make protein or enzyme called carbapenemase (genes: KPC, NDM, OXA, VIM, etc.) Carbapenemase: Enzymes that break down most antibiotics including carbapenems Enterobacteriaceae: A large family of bacteria present normally (part of gut flora) in the human intestinal tract or pathogenically (e.g., E.coli, Enterobacter, Klebsiella, etc.).

2017-09-28 3

PublicHealthOntario.ca

Acronyms: CPO,CPE,CRE,CRO

C Carbapenems (antibiotics) R Resistant P Producing (carbapenemase enzyme) O Organisms E Enterobacteriaceae

PublicHealthOntario.ca

Putting it All Together . . .

CRO Carbapenem Resistant Organism Any organism resistant to carbapenems antibiotics by a variety of ways, e.g., mutation, inherent resistance, and by production of carbapenemase (enzyme which breaks down antibiotics) CRE Carbapenem Resistant Enterobacteriaceae Enterobacteriaceae that are resistant to carbapenems by mutation, inherent resistance,

• r production of carbapenemase ( enzyme which breaks down

antibiotics)

2017-09-28 4

PublicHealthOntario.ca

Putting it All Together . . .

CPO Carbapenemase Producing Organism Any organism resistant to carbapenems by producing carbapenemase (enzyme which breaks down antibiotics) CPE Carbapenemase-Producing Enterobacteriaceae Enterobacteriaceae that are resistant to carbapenems by producing carbapenemase (enzyme which breaks down antibiotics)

PublicHealthOntario.ca

What is C-3PO?

Image source: https://en.wikipedia.org/wiki/C-3PO

2017-09-28 5

PublicHealthOntario.ca

Video

PublicHealthOntario.ca

Incidence of CPE in Peel and Ontario Is CPE a problem here?

2017-09-28 6

PublicHealthOntario.ca

Prevalence? Percentage of Ontario CPE Isolates in Peel LHINs (CW & MH)

28% 35% 43% 44% 50% 0% 10% 20% 30% 40% 50% 60% 2008-2012 2013 2014 2015 2016 Percentage

PublicHealthOntario.ca

Source of Isolates

2017-09-28 7

PublicHealthOntario.ca

Risk Factors for Acquiring CPE

Receiving healthcare outside of Canada, specifically in areas that have high prevalence of CPE for example, Greece, Israel, Eastern US, and Indian subcontinent Prolonged hospital stay Admission to ICU

Ventilation Surgery Infection

PublicHealthOntario.ca

Risk Factors for Acquiring CPE (continued)

Male > 60 years old Patient/residents with an indwelling device such as central venous catheter or urinary catheter Multiple exposure to different antibiotics

• Poor functional status:
• Diabetes mellitus
• End stage renal disease
• Cancer/chemotherapy

2017-09-28 8

PublicHealthOntario.ca

How is CPE Spread ?

Most people who have CPE present with no symptoms of infection and are said to be colonized Primary site of colonization is the lower gastrointestinal tract CPE can be spread from one person to another by unwashed hands (direct contact) or from contact with contaminated equipment and surfaces ( indirect contact) Infection occurs when CPE enters the body at a specific site and causes symptoms of disease for example, pneumonia and UTI CPE is resistant to many types of antibiotics hence treatment can be difficult and may involve antibiotics which have significant side effects

PublicHealthOntario.ca

Why is CPE a Concern ?

CPE infections have limited treatment options Can contribute to death in up to 50% of infected patients Highly transmissible leading to serious infection control implications

Image source: CDC

2017-09-28 9

PublicHealthOntario.ca PublicHealthOntario.ca

Duration of colonization

• Follow up screening (rectal swabs) of 97/137 CRE patients post-

discharge

• Time to clear – mean 387 days (95% CI; 312-463)

18

2017-09-28 10

PublicHealthOntario.ca

Preventing the Spread of CPE

Routine practices Contact precautions for CPE positive patients Cohorting Minimize use of invasive devices Promote antibiotic stewardship Screening

PublicHealthOntario.ca

Routine Practices

Including: Point of care risk assessment Hand hygiene - 4 moments Dedicate equipment where possible. Clean and disinfect shared equipment between patients/residents Environmental cleaning*

2017-09-28 11

PublicHealthOntario.ca

Contact Precautions

Single room or cohort with someone with the same organism

• Dedicated toilet/commode
• Dedicated equipment
• Wheelchair
• Feeding pump
• BP cuff
• Stethoscope

Gowns and gloves for care Environmental cleaning – attention to sinks

PublicHealthOntario.ca

Preventing the Spread of CPE (continued)

Dedicated hand hygiene sinks for hand washing only. Body fluids and bath water should not be disposed in these sinks Bathing with chlorhexidine Contact screening: minimum 3 sets of specimens taken on different days, with at least one taken 21 days after last exposure

2017-09-28 12

PublicHealthOntario.ca

Protecting Yourself from CPE

Avoid unnecessary exposures to health care measures in endemic countries Inform your healthcare professional if you had a medical procedure done recently while travelling to an endemic country Take antibiotics as prescribed Clean your own hands especially before preparing or eating food, before and after wound dressings, after using the bathroom, after coughing or sneezing Note: Health care workers have NOT been found to be at increased risk of CPE acquisition in the workplace – use RPAPs

PublicHealthOntario.ca

Scenario 1

The hospital is asking that your Home accept a new resident who has CPE. Are you obliged to accept this resident?

• Why or why not?

2017-09-28 13

PublicHealthOntario.ca

Scenario 2

A resident returns from hospital with a recent history of a CRO in her urine. What precautions and actions should you initiate?

PublicHealthOntario.ca

Scenario 3

You are the charge nurse at a LTCH. You receive a call from the local hospital to say that Mrs. Brown ( 87 years old) is returning back to the home now that she has recovered from pneumonia.

• Mrs. Brown is incontinent of stool and requires total care. Two days

after her transfer to LTCH, an ICP from the hospital calls to inform you that Mrs. Brown tested positive for CPE on a swab taken just before transfer to your Home. a) What would be your first steps to prevent CPE from spreading?

– Contact Precautions – Adherence to hand hygiene and PPE – Environmental cleaning – Ensuring shared equipment in between residents is being disinfected – Private room – Residents in close proximity should be screened for CPE (minimum 3 sets of specimens taken on different days, with at least one taken 21 days after last exposure

2017-09-28 14

PublicHealthOntario.ca

Scenario 3 - continued

b) Mrs. Brown’s daughter asks if she can take her mother out for a

• walk. How would you response to this request?
• Mrs. Brown can leave her room but the nurse should assist with hand

hygiene before and after entering her room. In addition, the nurse should ensure that Mrs. Brown’s clothes are clean; body fluids are contained and any lesions are covered.

PublicHealthOntario.ca

Resources

28

2017-09-28 15

PublicHealthOntario.ca

Key References

• Public Health Ontario. Carbapenemase-producing

Enterobacteriaceae (CPE). Available from https://www.publichealthontario.ca/en/BrowseByTopic/Infecti

• usDiseases/Pages/IDLandingPages/carbapenamase-

producing-enterobacteriaceae.aspx

• Provincial Infectious Diseases Advisory Committee. Routine

practices and additional precautions. Available from https://www.publichealthontario.ca/en/BrowseByTopic/Infecti

• usDiseases/PIDAC/Pages/Routine_Practices_Additional_Prec

autions.aspx

PublicHealthOntario.ca

Additional References

• Public Health England. Acute trust toolkit for the early detection,

management and control of Carbapenemase-producing

• Enterobacteriaceae. 2013. Available from

http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317140378646

• World Health Organization. Global action plan on antimicrobial resistance.
• 2015. Available from

http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng. pdf?ua=1

• “Antimicrobial Resistance - Animation of Antimicrobial Resistance.” U S

Food and Drug Administration (FDA), Center for Veterinary Medicine, 14 July 2014, www.fda.gov/animalveterinary/safetyhealth/antimicrobialresistance/ucm1 34359.htm

2017-09-28 16

PublicHealthOntario.ca

Additional References

• Centers for Disease Control. Facility guidance for control of Carbapenem-

resistant Enterobacteriaceae (CRE): November 2015 Update: CRE Toolkit. Available from http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf

• Mariappan S, Sekar U, Kamalanathan A.

Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes. Int J Appl Basic Med Res. 2017 Jan-Mar; 7(1): 32–39. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327604/

• Parker VA, Logan CK, Currie B. Carbapenem-Resistant Enterobacteriaceae (CRE)

control and prevention toolkit. (Prepared by Boston University School of Public Health and Montefiore Medical Center under Contract No. 290-2006-0012-l.) AHRQ Publication No. 14-0028. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. Available from http://www.ahrq.gov/sites/default/files/publications/files/cretoolkit.pdf